Kisspeptin-10 is the minimal bioactive fragment of Kisspeptin-54 — a hypothalamic neuropeptide that serves as the master "pulse generator" for the entire HPG (Hypothalamic-Pituitary-Gonadal) axis. Without kisspeptin signaling, GnRH secretion ceases, LH and FSH fall to zero, and gonadal steroidogenesis stops entirely. Kisspeptin is not a peripheral modulator — it is the upstream gate that controls whether the HPG axis runs at all.

The HPG Axis Master Control

The HPG axis hierarchy: 1. Kisspeptin neurons (hypothalamus) → activate GnRH neurons 2. GnRH (from hypothalamus) → stimulates pituitary LH and FSH release 3. LH (from pituitary) → drives Leydig cell testosterone production 4. FSH (from pituitary) → drives spermatogenesis and gonadal development

Kisspeptin is the first step in this cascade. It acts as the upstream integrator of metabolic, hormonal, and environmental signals that determine whether the reproductive axis is activated. Kisspeptin neurons receive input from leptin, insulin, thyroid hormones, cortisol, and circadian rhythms — and integrate all of these signals to determine appropriate GnRH pulse frequency and amplitude.

Kisspeptin-10 vs. Kisspeptin-54

Kisspeptin-54 (the full 54-amino acid peptide) has a short half-life and is difficult to synthesize. Kisspeptin-10 (the 10 C-terminal amino acids, residues 45-54) contains the full binding activity for the KiSS1 receptor (KISS1R, also known as GPR54) and is the biologically active minimum sequence. It retains the full pharmacological potency of the parent peptide at much lower manufacturing complexity.

KiSS1R Receptor Mechanism

Kisspeptin-10 binds the KISS1R Gq-coupled receptor on GnRH neurons. This triggers: - Intracellular calcium release - GnRH neuron depolarization and firing - Pulsatile GnRH secretion - Downstream LH and FSH pulses

The pulsatile nature of kisspeptin administration is critical: pulsatile kisspeptin stimulates LH release, while continuous kisspeptin infusion desensitizes KISS1R and suppresses the HPG axis (analogous to how continuous GnRH agonists downregulate LH through desensitization).

Clinical Research Applications

Kisspeptin has been studied in multiple clinical contexts: - HPG axis restoration: Used as a pharmacological tool to restore GnRH pulsatility in hypothalamic amenorrhea - Testosterone optimization: Human studies show kisspeptin administration drives LH surges and testosterone elevation in healthy men - HPG axis suppression recovery: Post-exogenous androgen exposure, kisspeptin may accelerate recovery of the suppressed HPG axis by stimulating GnRH neurons upstream of the pituitary - Fertility research: GnRH-stimulating effects used in reproductive medicine for ovulation induction and timing

Research Note on Pulsatile Administration

The HPG axis is inherently pulsatile — GnRH, LH, and testosterone are all secreted in pulses rather than continuously. Kisspeptin-10 protocols must mimic this pulsatile pattern: intermittent injections 2–3× weekly are far more effective than daily or continuous administration, which leads to receptor desensitization and paradoxical HPG suppression.